Title : Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.

Pub. Date : 2020 Nov

PMID : 32961616






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we explore enhancement of the effect of irinotecan [camptothecin-11 (CPT-11)] by the p53-dependent induction of carboxylesterase 2 (CES2), a CPT-11-activating enzyme, in MM. Irinotecan tumor protein p53 Homo sapiens
2 Here, we explore enhancement of the effect of irinotecan [camptothecin-11 (CPT-11)] by the p53-dependent induction of carboxylesterase 2 (CES2), a CPT-11-activating enzyme, in MM. Irinotecan tumor protein p53 Homo sapiens
3 Here, we explore enhancement of the effect of irinotecan [camptothecin-11 (CPT-11)] by the p53-dependent induction of carboxylesterase 2 (CES2), a CPT-11-activating enzyme, in MM. Irinotecan tumor protein p53 Homo sapiens
4 Here, we explore enhancement of the effect of irinotecan [camptothecin-11 (CPT-11)] by the p53-dependent induction of carboxylesterase 2 (CES2), a CPT-11-activating enzyme, in MM. Irinotecan tumor protein p53 Homo sapiens